<html><head><title>Berndt Hšppner mutations</title><meta http-equiv="Content-Type" content="text/html"><meta http-equiv="Author" name="Berndt Hšppner" content="mutations"><meta http-equiv="Author" name="mutations" content="jeden"><meta name="Language" content="de-en"><meta name="Keywords" lang="de" content="mutations, Berndt Hšppner, jeden"><meta name="Keywords" lang="en" content="Berndt Hšppner, mutations, , jeden"><meta name="Description" lang="al "content=" A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Amutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Specific mutations of the RET proto-oncogene are related to disease phenotype in NEM 2a and FMTC."><meta name="Revisit-after" content="1 month"><meta name="Date_modified" content="2001-06-13"><meta name="ROBOTS" content="index,follow"></head><style type="text/css"> 	A.nav:link {TEXT-DECORATION: none}	A.nav:visited {TEXT-DECORATION: none} 	A.nav:visited {TEXT-DECORATION: none}	A.nav:active {TEXT-DECORATION: none}	A.nav:hover {TEXT-DECORATION: none}	</style><body bgcolor="#FFFFF">	<font face="arial" size="3" color="#000000">	<table border="0" cellpadding="0" cellspacing="0" width="100%">	<tr><td><a href="jeden.html" class="nav">jeden</a></td></tr>	<tr><td><a href="index.html" class="nav">home page</a></td></tr></table>	<br><div align="center"><font size="6">- mutations -<br><br></font></div><table width="100%" border="0" cellspacing="0" cellpadding="1"<td valign="center"> In contrast to these rare events, heterozygous missense mutations in exon 13, codons 790 and 791, were found in 5 families (4 with MTC only; 1 family with MTC and pheochromocytoma) and 11 patients with apparently sporadic tumors. . A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. One hundred and eighty-one families with multiple endocrine neoplasia type 2A (MEN-2A) or familial medullary thyroid carcinoma (FMTC) have been investigated for mutations in the ret protooncogene in Germany. In 8 families with FMTC or MEN-2A, no mutation could be detected in the cysteine-rich domain encoded in exons 10 and 11 of the ret protooncogene.</td><tr></table><table width="100%" border="0" cellspacing="1" cellpadding="5"<td valign="top"> Bei Nachweis der MEN2B-Mutation ist aufgrund des aggressiven Verlaufs die Operation bereits im 1. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Menin mutations in patients with multiple endocrine neoplasia type 1. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1.</td><td valign="top"><img HEIGHT="104" WIDTH="104" src="http://www.uke.uni-hamburg.de/forschung/grk336/Forschung//images/siegel-forschung.gif"></td><tr></table><table width="100%" border="0" cellspacing="1" cellpadding="3"><td valign="bottom"> A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Amutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Specific mutations of the RET proto-oncogene are related to disease phenotype in NEM 2a and FMTC.</td><tr></table><table width="100%" border="0" cellspacing="1" cellpadding="5"><td valign="bottom"> Bei ihnen kann gezielt nach der Mutation des Index-Patienten gesucht werden. A RET double mutation in the germline of a kindred with FMTC. A new hot spot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A, J. Evidence for calcitonin - a new hormone from the parathyroid that lowers blood calcium. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.</td><tr></table><br>read more at: <a href="http://www.blackwell-synergy.com/Journals/member/processpaid.asp?contentid=eci.2000.5&filetype=articles&article=56236&year=&journal=">http://www.blackwell-synergy.com/Journals/member/processpaid.asp?contentid=eci.2000.5&filetype=articles&article=56236&year=&journal=</a><br><br></font><font size=-6> <a class="nav" href="http://www.krungkuene.org/~werner/117/index.html">.</a><br><br></font></body></html>